Clinical Trial Detail

NCT ID NCT02437071
Title Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal cancer

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.